miR-20a-5p regulated SMAD6 to inhibit chondrogenesis of hDPSCs.
Xuefeng PanXinqi HuangBo ZhangFang PeiZhi-He ZhaoXiao CenPublished in: Oral diseases (2022)
miR-20a-5p could target SMAD6 to activate NF-κB signaling pathway, and thus inhibit chondrogenesis of hDPSCs, which provided promising therapeutic target for cartilage defects clinically.